Drug Trial Radar · NCT00934921
Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions
Last checked: Nov 19, 2026Latest source record: Aug 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
24
Actual
Start
Feb 2003
Primary completion
Feb 2003
Study completion Feb 2003
Sponsor
- Lead sponsor
- Teva Pharmaceuticals USATeva (TEVA)
- Sponsor type
- Industry
- First posted
- Jul 8, 2009
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study was to compare the relative bioavailability of the test formulation of Ondansetron HCl with the already marketed reference formulation Zofran® ODT under non-fasting conditions in healthy, non-smoking, adult subjects.
Conditions
- Healthy
Interventions
OndansetronDrug
1 x 8 mg Orally Disintegrating Tablet
Zofran®Drug
1 x 8 mg ODT
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax - Maximum Observed ConcentrationTime frame: Blood samples collected over 24 hour period
- AUC0-inf - Area Under the Concentration-time Curve From Time Zero to Infinity (Extrapolated)Time frame: Blood samples collected over 24 hour period
- AUC0-t - Area Under the Concentration-time Curve From Time Zero to Time of Last Non-zero Concentration (Per Participant)Time frame: Blood samples collected over 24 hour period
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Novum Pharmaceutical Research Services
Houston, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.